SlideShare a Scribd company logo
Pharmaceutical Regulatory Authorities
Of India
SEMINAR PRESENTATION
Prepared by:- Rutuja Nale
First year
M.Pharm semester 2 (PQA)
Rajarambapu College Of Pharmacy
Kasegaon
Guided by:- Prof. Archna Dhole
1
Date :- 8 June 2021
2
Content:-
• Introduction
• Regulatory Bodies
1. Central drug standard control organization (CDSCO)
2. Indian pharmaceutical association (IPA)
3. Drug technical advisory board (DTAB)
4. Central drug testing laboratory (CDTL)
5. Indian pharmacopoeia commission (IPC)
6. National pharmaceutical pricing authority (NPPA)
7. Indian council of medical research (ICMR)
• DETAILS OF
1. World health organization (WHO)
2. AYUSH
3. ICMR
India’s Ministry of Health and Family Welfare (MoHFW)
1. Central drug standard control organization
(CDSCO)
2. Indian pharmaceutical association (IPA)
3. Drug technical advisory board(DTAB)
4. Central drug testing laboratory (CDTL)
5. Indian pharmacopoeia commission (IPC)
6. National pharmaceutical pricing authority (NPPA)
7. Indian council of medical research (ICMR)
3
SIX- ZONAL OFFICES
Mumbai, Kolkata, Chennai , Ghaziabad ,
ahmedabad,
Hyderabad
Seven laboratories
Kolkata,Mumbai, Chennai,kasauli ,
gujarati,
Chandigarh, Hyderabad
Port offices
Delhi, Kolkata, Indore, Hyderabad , Cochin,
Visakhapatnam, krishnapatnam ,
Ahmadabad,Bangalore, Hazira,
Goa, Mumbai , Chennai
Sub – zonal offices
Benguluru , Varanasi, Goa , Jammu and
Kashmir ,
Indore , Guwahati, Bandi
CDSCO
HEADQUARTERS
4
5
Drug approval process:-
6
7
• CDSCO is constantly thriving upon to bring out transparency,
accountability and uniformity in its services in order to ensure safety,
efficacy and quality of the medical product manufactured,imported
and distributed in the country.
Under the Drugs and Cosmetics Act, CDSCO is responsible for
approvalof Drugs, Conduct of Clinical Trials, laying down the
standards for Drugs, control over the quality of imported Drugs in the
country and coordination of the activities of State Drug Control
Organizationsby providing expert advice with a view of bring
about the uniformity in the enforcement of the Drugs and Cosmetics
Act.
8
• Sugam builds a comprehensive database of the various permissions and
licenses issued by State FDAs.
• This includes details of manufacturers, manufacturing site and drug
formulations.
• Manufacturer can view their consolidated data about permissions issued
to them from State FDA.
INDIAN PHARMACEUTICAL ASSOCIATION
9
• Connecting The Pharmacistsand Pharmaceutical Scientists of India — The
Indian PharmaceuticalAssociation (IPA) is the National body representing
over 1 million pharmacists and pharmaceuticalscientists from Industry,
Academia, Regulatory, Hospital and Community Pharmacy and work to
meet the India’s health care needs.
• IPA is a non-governmentalorganization that has been in official relations
with the FIP and WHO.
• IPA is member of Drug Technical Advisory Board (DTAB), Ministry of Health
and Family Welfare, Government of India.
• IPA has been awarded “Best Professional Organisation Award -2015” by
Indian Association Congress.
IPA PUBLICATION
10
Drugs Technical Advisory Board
•Drugs Technical Advisory Board is a statutory body constituted under the Drugs and Cosmetics
Act, 1940.
•The function of DTAB is to advise the Central government and State government on technical
matters related to drugs and cosmetics.
Section 3 of the Drugs and Cosmetics Act, 1940
•The Central Government, after consultation with
the Drugs Technical Advisory Board (DTAB),
specifies the devices intended for use in human
beings or animals as drugs.
11
1.Central Drugs Testing Laboratory, Mumbai, Maharashtra
2.Central Drugs Laboratory, Kolkata, West Bengal
3.Central Drugs Testing Laboratory, Chennai, Tamil Nadu
4.Central Drugs Testing Laboratory, Hyderabad, Andhra Pradesh
5.Central Drugs Laboratory, Central Research Institute, Kasauli, Himachal
Pradesh
6.Regional Drugs Testing Laboratory, Guwahati, Assam
7.Regional Drugs Testing Laboratory, Chandigarh
A. Central Drugs Testing Laboratories
12
13
14
The National Pharmaceutical Pricing Authority (NPPA) is a government regulatory agency that
controls the prices of pharmaceutical drugs in India.[1].National Pharmaceutical Pricing Authority
(NPPA) was constituted vide Government of India Resolution dated 29th August, 1997 as an
attached office of the Department of Pharmaceuticals (DoP), Ministry of Chemicals and
Fertilizers as an independent Regulator for pricing of drugs and to ensure availability and
accessibility of medicines at affordable prices.
15
The World Health Organization is a specialized agency of the United Nations responsible for
international public health. The WHO Constitution, which establishes the agency's governing
structure and principles, states its main objective as "the attainment by all peoples of the highest
possible level of health".
What is the WHO definition of health?
Health is a state of complete physical, mental and social well-being and not merely the
absence of disease or infirmity.
16
17
The Indian Council of Medical Research (ICMR), New Delhi, the apex body in India for
the formulation, coordination and promotion of biomedical research, is one of the oldest
medical research bodies in the world.
The Council's research priorities coincide with the National health priorities, such as: control and
management of communicable diseases, fertility control, maternal and child health, control of
nutritional disorders, developing alternative strategies for health care delivery, containment
within safety limits of environmental and occupational health problems; research on major non-
communicable diseases like cancer, cardiovascular diseases, blindness, diabetes and other
metabolic and haematological disorders; and mental health research and drug research
(including traditional remedies).
18
19
20
21
22
23

More Related Content

What's hot

UNIT 4 TOPIC Managing Monitoring Clinical Trials.pdf
UNIT 4 TOPIC Managing Monitoring Clinical Trials.pdfUNIT 4 TOPIC Managing Monitoring Clinical Trials.pdf
UNIT 4 TOPIC Managing Monitoring Clinical Trials.pdf
Dr Yogi Pandya
 
Basic terminologies used in pharmacovigilance.pptx
Basic terminologies used in pharmacovigilance.pptxBasic terminologies used in pharmacovigilance.pptx
Basic terminologies used in pharmacovigilance.pptx
ReshmaManeDeshmukh
 
overview of Japan pharmaceutical regulatory authority - PMDA
overview of Japan  pharmaceutical regulatory authority - PMDAoverview of Japan  pharmaceutical regulatory authority - PMDA
overview of Japan pharmaceutical regulatory authority - PMDA
Nandhanan
 
Schedule Y
Schedule YSchedule Y
Schedule Y
kamalakar ambati
 
Guidance for industry changes to an approved nda or anda
Guidance for industry changes to an approved nda or andaGuidance for industry changes to an approved nda or anda
Guidance for industry changes to an approved nda or anda
Gaurav Sharma
 
ind
indind
CENTRAL DRUG STANDARD CONTROL ORGANISATION (CDSCO)
CENTRAL DRUG STANDARD CONTROL ORGANISATION  (CDSCO)CENTRAL DRUG STANDARD CONTROL ORGANISATION  (CDSCO)
CENTRAL DRUG STANDARD CONTROL ORGANISATION (CDSCO)
Vijay Banwala
 
Regulatory requirnment and approval procedure of drugs in japan ppt
Regulatory requirnment and approval procedure of drugs in japan pptRegulatory requirnment and approval procedure of drugs in japan ppt
Regulatory requirnment and approval procedure of drugs in japan ppt
sandeep bansal
 
GCP for Investigators by Valentyna
GCP for Investigators by ValentynaGCP for Investigators by Valentyna
GCP for Investigators by ValentynaValentyna Korniyenko
 
Investigational new drug (IND)
Investigational new drug (IND)Investigational new drug (IND)
Investigational new drug (IND)
Manish Rajput
 
Unit-III, Chapter 1. Registration of Indian Products in Overseas Market.
Unit-III, Chapter 1. Registration of Indian Products in Overseas Market.Unit-III, Chapter 1. Registration of Indian Products in Overseas Market.
Unit-III, Chapter 1. Registration of Indian Products in Overseas Market.
Audumbar Mali
 
Registration of Indian Drug Product in Overseas Market.pptx
Registration of Indian Drug Product in Overseas Market.pptxRegistration of Indian Drug Product in Overseas Market.pptx
Registration of Indian Drug Product in Overseas Market.pptx
Nipun Gupta
 
ICH safety guidelines
ICH safety guidelinesICH safety guidelines
ICH safety guidelines
vishnu Jatoth
 
INDA/NDA/ANDA
INDA/NDA/ANDAINDA/NDA/ANDA
INDA/NDA/ANDA
Rohit Bhosale
 
WHO international drug monitoring programme.pptx
WHO international drug monitoring programme.pptxWHO international drug monitoring programme.pptx
WHO international drug monitoring programme.pptx
ReshmaManeDeshmukh
 
eCTD
eCTDeCTD
Ind (investigational new drug application) and nda
Ind (investigational new drug application) and ndaInd (investigational new drug application) and nda
Ind (investigational new drug application) and ndaswati2084
 
EUROPEAN MEDICAL AGENCY
EUROPEAN MEDICAL AGENCYEUROPEAN MEDICAL AGENCY
EUROPEAN MEDICAL AGENCY
datchayani
 
Electronic Common Technical Document (eCTD)
Electronic Common Technical Document (eCTD)Electronic Common Technical Document (eCTD)
Electronic Common Technical Document (eCTD)
Md. Zakaria Faruki
 
History of Pharmacovigilance
History of PharmacovigilanceHistory of Pharmacovigilance
History of Pharmacovigilance
Dr. Ramesh Bhandari
 

What's hot (20)

UNIT 4 TOPIC Managing Monitoring Clinical Trials.pdf
UNIT 4 TOPIC Managing Monitoring Clinical Trials.pdfUNIT 4 TOPIC Managing Monitoring Clinical Trials.pdf
UNIT 4 TOPIC Managing Monitoring Clinical Trials.pdf
 
Basic terminologies used in pharmacovigilance.pptx
Basic terminologies used in pharmacovigilance.pptxBasic terminologies used in pharmacovigilance.pptx
Basic terminologies used in pharmacovigilance.pptx
 
overview of Japan pharmaceutical regulatory authority - PMDA
overview of Japan  pharmaceutical regulatory authority - PMDAoverview of Japan  pharmaceutical regulatory authority - PMDA
overview of Japan pharmaceutical regulatory authority - PMDA
 
Schedule Y
Schedule YSchedule Y
Schedule Y
 
Guidance for industry changes to an approved nda or anda
Guidance for industry changes to an approved nda or andaGuidance for industry changes to an approved nda or anda
Guidance for industry changes to an approved nda or anda
 
ind
indind
ind
 
CENTRAL DRUG STANDARD CONTROL ORGANISATION (CDSCO)
CENTRAL DRUG STANDARD CONTROL ORGANISATION  (CDSCO)CENTRAL DRUG STANDARD CONTROL ORGANISATION  (CDSCO)
CENTRAL DRUG STANDARD CONTROL ORGANISATION (CDSCO)
 
Regulatory requirnment and approval procedure of drugs in japan ppt
Regulatory requirnment and approval procedure of drugs in japan pptRegulatory requirnment and approval procedure of drugs in japan ppt
Regulatory requirnment and approval procedure of drugs in japan ppt
 
GCP for Investigators by Valentyna
GCP for Investigators by ValentynaGCP for Investigators by Valentyna
GCP for Investigators by Valentyna
 
Investigational new drug (IND)
Investigational new drug (IND)Investigational new drug (IND)
Investigational new drug (IND)
 
Unit-III, Chapter 1. Registration of Indian Products in Overseas Market.
Unit-III, Chapter 1. Registration of Indian Products in Overseas Market.Unit-III, Chapter 1. Registration of Indian Products in Overseas Market.
Unit-III, Chapter 1. Registration of Indian Products in Overseas Market.
 
Registration of Indian Drug Product in Overseas Market.pptx
Registration of Indian Drug Product in Overseas Market.pptxRegistration of Indian Drug Product in Overseas Market.pptx
Registration of Indian Drug Product in Overseas Market.pptx
 
ICH safety guidelines
ICH safety guidelinesICH safety guidelines
ICH safety guidelines
 
INDA/NDA/ANDA
INDA/NDA/ANDAINDA/NDA/ANDA
INDA/NDA/ANDA
 
WHO international drug monitoring programme.pptx
WHO international drug monitoring programme.pptxWHO international drug monitoring programme.pptx
WHO international drug monitoring programme.pptx
 
eCTD
eCTDeCTD
eCTD
 
Ind (investigational new drug application) and nda
Ind (investigational new drug application) and ndaInd (investigational new drug application) and nda
Ind (investigational new drug application) and nda
 
EUROPEAN MEDICAL AGENCY
EUROPEAN MEDICAL AGENCYEUROPEAN MEDICAL AGENCY
EUROPEAN MEDICAL AGENCY
 
Electronic Common Technical Document (eCTD)
Electronic Common Technical Document (eCTD)Electronic Common Technical Document (eCTD)
Electronic Common Technical Document (eCTD)
 
History of Pharmacovigilance
History of PharmacovigilanceHistory of Pharmacovigilance
History of Pharmacovigilance
 

Similar to Pharmaceutical regulatory authorities of India

Role of all the Govt. pharma regulator Bodies.pptx
Role of all the Govt. pharma regulator Bodies.pptxRole of all the Govt. pharma regulator Bodies.pptx
Role of all the Govt. pharma regulator Bodies.pptx
nilimasakharkar1
 
International Regulatory agencies
International Regulatory agenciesInternational Regulatory agencies
International Regulatory agenciesBeena Maddi
 
Regulatory agencies
Regulatory agenciesRegulatory agencies
Regulatory agenciesBeena Maddi
 
Pharma Malpractices - Report of the Parliament Committee to Rajya Sabha
Pharma Malpractices - Report of the Parliament Committee to Rajya Sabha Pharma Malpractices - Report of the Parliament Committee to Rajya Sabha
Pharma Malpractices - Report of the Parliament Committee to Rajya Sabha
Anup Soans
 
The drugs and cosmetics act and rules cosmetics-mnz
The drugs and cosmetics act and rules  cosmetics-mnzThe drugs and cosmetics act and rules  cosmetics-mnz
The drugs and cosmetics act and rules cosmetics-mnz
maitreyi zaveri
 
Drug regulatory authority
Drug regulatory authority Drug regulatory authority
Drug regulatory authority
Rahul Gawande
 
Drug Regulatory Agencies.
 Drug Regulatory Agencies. Drug Regulatory Agencies.
Drug Regulatory Agencies.
Priyanka Chakote
 
Regulatory Issues for ASU.ppt by Dr.U.Srinivasa
Regulatory Issues for ASU.ppt by Dr.U.SrinivasaRegulatory Issues for ASU.ppt by Dr.U.Srinivasa
Regulatory Issues for ASU.ppt by Dr.U.Srinivasa
Srinivas college of pharmacy, Mangalore
 
Regulatory agencies
Regulatory agenciesRegulatory agencies
Regulatory agencies
Shaik Sana
 
Regulatory Control in Pharmaceutical Analysis
Regulatory Control in Pharmaceutical AnalysisRegulatory Control in Pharmaceutical Analysis
Regulatory Control in Pharmaceutical Analysis
Dr Duggirala Mahendra
 
Bodies regulating indian pharmaceutical sector, cdsco
Bodies regulating indian pharmaceutical sector, cdscoBodies regulating indian pharmaceutical sector, cdsco
Bodies regulating indian pharmaceutical sector, cdsco
chiranjibi68
 
Drug Regulatory
Drug RegulatoryDrug Regulatory
Drug Regulatory
Gauhar Nayab
 
Indian Regulatory Requirements
Indian Regulatory RequirementsIndian Regulatory Requirements
Indian Regulatory Requirements
Audumbar Mali
 
pharma assignment .pptx
pharma assignment .pptxpharma assignment .pptx
pharma assignment .pptx
TUSHARKUMAR784538
 
pharmaceutical associations, societies and statutory councils
pharmaceutical associations, societies and statutory councils pharmaceutical associations, societies and statutory councils
pharmaceutical associations, societies and statutory councils Haniya Zaheer
 
NFUM Part VI.pdf
NFUM Part VI.pdfNFUM Part VI.pdf
NFUM Part VI.pdf
Dr. Shabistan Fatma Taiyabi
 
Lecture 3: QC and QA-International perspective of USA, WHO, ICH & India
Lecture 3: QC and QA-International perspective of USA, WHO, ICH & IndiaLecture 3: QC and QA-International perspective of USA, WHO, ICH & India
Lecture 3: QC and QA-International perspective of USA, WHO, ICH & India
Sapan Shah
 
regulaotryauthorities-160426054815.pdf
regulaotryauthorities-160426054815.pdfregulaotryauthorities-160426054815.pdf
regulaotryauthorities-160426054815.pdf
Vhuii
 
Regulatory authorities (US-FDA, WHO and ICH)
Regulatory authorities (US-FDA, WHO and ICH)Regulatory authorities (US-FDA, WHO and ICH)
Regulatory authorities (US-FDA, WHO and ICH)
Sagar Savale
 
Asu drug regulations in india
Asu drug regulations in indiaAsu drug regulations in india
Asu drug regulations in india
ARAVIND R
 

Similar to Pharmaceutical regulatory authorities of India (20)

Role of all the Govt. pharma regulator Bodies.pptx
Role of all the Govt. pharma regulator Bodies.pptxRole of all the Govt. pharma regulator Bodies.pptx
Role of all the Govt. pharma regulator Bodies.pptx
 
International Regulatory agencies
International Regulatory agenciesInternational Regulatory agencies
International Regulatory agencies
 
Regulatory agencies
Regulatory agenciesRegulatory agencies
Regulatory agencies
 
Pharma Malpractices - Report of the Parliament Committee to Rajya Sabha
Pharma Malpractices - Report of the Parliament Committee to Rajya Sabha Pharma Malpractices - Report of the Parliament Committee to Rajya Sabha
Pharma Malpractices - Report of the Parliament Committee to Rajya Sabha
 
The drugs and cosmetics act and rules cosmetics-mnz
The drugs and cosmetics act and rules  cosmetics-mnzThe drugs and cosmetics act and rules  cosmetics-mnz
The drugs and cosmetics act and rules cosmetics-mnz
 
Drug regulatory authority
Drug regulatory authority Drug regulatory authority
Drug regulatory authority
 
Drug Regulatory Agencies.
 Drug Regulatory Agencies. Drug Regulatory Agencies.
Drug Regulatory Agencies.
 
Regulatory Issues for ASU.ppt by Dr.U.Srinivasa
Regulatory Issues for ASU.ppt by Dr.U.SrinivasaRegulatory Issues for ASU.ppt by Dr.U.Srinivasa
Regulatory Issues for ASU.ppt by Dr.U.Srinivasa
 
Regulatory agencies
Regulatory agenciesRegulatory agencies
Regulatory agencies
 
Regulatory Control in Pharmaceutical Analysis
Regulatory Control in Pharmaceutical AnalysisRegulatory Control in Pharmaceutical Analysis
Regulatory Control in Pharmaceutical Analysis
 
Bodies regulating indian pharmaceutical sector, cdsco
Bodies regulating indian pharmaceutical sector, cdscoBodies regulating indian pharmaceutical sector, cdsco
Bodies regulating indian pharmaceutical sector, cdsco
 
Drug Regulatory
Drug RegulatoryDrug Regulatory
Drug Regulatory
 
Indian Regulatory Requirements
Indian Regulatory RequirementsIndian Regulatory Requirements
Indian Regulatory Requirements
 
pharma assignment .pptx
pharma assignment .pptxpharma assignment .pptx
pharma assignment .pptx
 
pharmaceutical associations, societies and statutory councils
pharmaceutical associations, societies and statutory councils pharmaceutical associations, societies and statutory councils
pharmaceutical associations, societies and statutory councils
 
NFUM Part VI.pdf
NFUM Part VI.pdfNFUM Part VI.pdf
NFUM Part VI.pdf
 
Lecture 3: QC and QA-International perspective of USA, WHO, ICH & India
Lecture 3: QC and QA-International perspective of USA, WHO, ICH & IndiaLecture 3: QC and QA-International perspective of USA, WHO, ICH & India
Lecture 3: QC and QA-International perspective of USA, WHO, ICH & India
 
regulaotryauthorities-160426054815.pdf
regulaotryauthorities-160426054815.pdfregulaotryauthorities-160426054815.pdf
regulaotryauthorities-160426054815.pdf
 
Regulatory authorities (US-FDA, WHO and ICH)
Regulatory authorities (US-FDA, WHO and ICH)Regulatory authorities (US-FDA, WHO and ICH)
Regulatory authorities (US-FDA, WHO and ICH)
 
Asu drug regulations in india
Asu drug regulations in indiaAsu drug regulations in india
Asu drug regulations in india
 

Recently uploaded

PART A. Introduction to Costumer Service
PART A. Introduction to Costumer ServicePART A. Introduction to Costumer Service
PART A. Introduction to Costumer Service
PedroFerreira53928
 
Template Jadual Bertugas Kelas (Boleh Edit)
Template Jadual Bertugas Kelas (Boleh Edit)Template Jadual Bertugas Kelas (Boleh Edit)
Template Jadual Bertugas Kelas (Boleh Edit)
rosedainty
 
How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...
Jisc
 
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCECLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
BhavyaRajput3
 
ESC Beyond Borders _From EU to You_ InfoPack general.pdf
ESC Beyond Borders _From EU to You_ InfoPack general.pdfESC Beyond Borders _From EU to You_ InfoPack general.pdf
ESC Beyond Borders _From EU to You_ InfoPack general.pdf
Fundacja Rozwoju Społeczeństwa Przedsiębiorczego
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
siemaillard
 
How to Break the cycle of negative Thoughts
How to Break the cycle of negative ThoughtsHow to Break the cycle of negative Thoughts
How to Break the cycle of negative Thoughts
Col Mukteshwar Prasad
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
Special education needs
 
Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345
beazzy04
 
Sectors of the Indian Economy - Class 10 Study Notes pdf
Sectors of the Indian Economy - Class 10 Study Notes pdfSectors of the Indian Economy - Class 10 Study Notes pdf
Sectors of the Indian Economy - Class 10 Study Notes pdf
Vivekanand Anglo Vedic Academy
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
MysoreMuleSoftMeetup
 
How to Create Map Views in the Odoo 17 ERP
How to Create Map Views in the Odoo 17 ERPHow to Create Map Views in the Odoo 17 ERP
How to Create Map Views in the Odoo 17 ERP
Celine George
 
Additional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdfAdditional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdf
joachimlavalley1
 
The geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideasThe geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideas
GeoBlogs
 
How to Split Bills in the Odoo 17 POS Module
How to Split Bills in the Odoo 17 POS ModuleHow to Split Bills in the Odoo 17 POS Module
How to Split Bills in the Odoo 17 POS Module
Celine George
 
Language Across the Curriculm LAC B.Ed.
Language Across the  Curriculm LAC B.Ed.Language Across the  Curriculm LAC B.Ed.
Language Across the Curriculm LAC B.Ed.
Atul Kumar Singh
 
The Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdfThe Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdf
kaushalkr1407
 
The Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official PublicationThe Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official Publication
Delapenabediema
 
Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
Pavel ( NSTU)
 
Basic phrases for greeting and assisting costumers
Basic phrases for greeting and assisting costumersBasic phrases for greeting and assisting costumers
Basic phrases for greeting and assisting costumers
PedroFerreira53928
 

Recently uploaded (20)

PART A. Introduction to Costumer Service
PART A. Introduction to Costumer ServicePART A. Introduction to Costumer Service
PART A. Introduction to Costumer Service
 
Template Jadual Bertugas Kelas (Boleh Edit)
Template Jadual Bertugas Kelas (Boleh Edit)Template Jadual Bertugas Kelas (Boleh Edit)
Template Jadual Bertugas Kelas (Boleh Edit)
 
How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...
 
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCECLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
 
ESC Beyond Borders _From EU to You_ InfoPack general.pdf
ESC Beyond Borders _From EU to You_ InfoPack general.pdfESC Beyond Borders _From EU to You_ InfoPack general.pdf
ESC Beyond Borders _From EU to You_ InfoPack general.pdf
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
 
How to Break the cycle of negative Thoughts
How to Break the cycle of negative ThoughtsHow to Break the cycle of negative Thoughts
How to Break the cycle of negative Thoughts
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
 
Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345
 
Sectors of the Indian Economy - Class 10 Study Notes pdf
Sectors of the Indian Economy - Class 10 Study Notes pdfSectors of the Indian Economy - Class 10 Study Notes pdf
Sectors of the Indian Economy - Class 10 Study Notes pdf
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
 
How to Create Map Views in the Odoo 17 ERP
How to Create Map Views in the Odoo 17 ERPHow to Create Map Views in the Odoo 17 ERP
How to Create Map Views in the Odoo 17 ERP
 
Additional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdfAdditional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdf
 
The geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideasThe geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideas
 
How to Split Bills in the Odoo 17 POS Module
How to Split Bills in the Odoo 17 POS ModuleHow to Split Bills in the Odoo 17 POS Module
How to Split Bills in the Odoo 17 POS Module
 
Language Across the Curriculm LAC B.Ed.
Language Across the  Curriculm LAC B.Ed.Language Across the  Curriculm LAC B.Ed.
Language Across the Curriculm LAC B.Ed.
 
The Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdfThe Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdf
 
The Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official PublicationThe Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official Publication
 
Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
 
Basic phrases for greeting and assisting costumers
Basic phrases for greeting and assisting costumersBasic phrases for greeting and assisting costumers
Basic phrases for greeting and assisting costumers
 

Pharmaceutical regulatory authorities of India

  • 1. Pharmaceutical Regulatory Authorities Of India SEMINAR PRESENTATION Prepared by:- Rutuja Nale First year M.Pharm semester 2 (PQA) Rajarambapu College Of Pharmacy Kasegaon Guided by:- Prof. Archna Dhole 1 Date :- 8 June 2021
  • 2. 2 Content:- • Introduction • Regulatory Bodies 1. Central drug standard control organization (CDSCO) 2. Indian pharmaceutical association (IPA) 3. Drug technical advisory board (DTAB) 4. Central drug testing laboratory (CDTL) 5. Indian pharmacopoeia commission (IPC) 6. National pharmaceutical pricing authority (NPPA) 7. Indian council of medical research (ICMR) • DETAILS OF 1. World health organization (WHO) 2. AYUSH 3. ICMR
  • 3. India’s Ministry of Health and Family Welfare (MoHFW) 1. Central drug standard control organization (CDSCO) 2. Indian pharmaceutical association (IPA) 3. Drug technical advisory board(DTAB) 4. Central drug testing laboratory (CDTL) 5. Indian pharmacopoeia commission (IPC) 6. National pharmaceutical pricing authority (NPPA) 7. Indian council of medical research (ICMR) 3
  • 4. SIX- ZONAL OFFICES Mumbai, Kolkata, Chennai , Ghaziabad , ahmedabad, Hyderabad Seven laboratories Kolkata,Mumbai, Chennai,kasauli , gujarati, Chandigarh, Hyderabad Port offices Delhi, Kolkata, Indore, Hyderabad , Cochin, Visakhapatnam, krishnapatnam , Ahmadabad,Bangalore, Hazira, Goa, Mumbai , Chennai Sub – zonal offices Benguluru , Varanasi, Goa , Jammu and Kashmir , Indore , Guwahati, Bandi CDSCO HEADQUARTERS 4
  • 5. 5
  • 7. 7 • CDSCO is constantly thriving upon to bring out transparency, accountability and uniformity in its services in order to ensure safety, efficacy and quality of the medical product manufactured,imported and distributed in the country. Under the Drugs and Cosmetics Act, CDSCO is responsible for approvalof Drugs, Conduct of Clinical Trials, laying down the standards for Drugs, control over the quality of imported Drugs in the country and coordination of the activities of State Drug Control Organizationsby providing expert advice with a view of bring about the uniformity in the enforcement of the Drugs and Cosmetics Act.
  • 8. 8 • Sugam builds a comprehensive database of the various permissions and licenses issued by State FDAs. • This includes details of manufacturers, manufacturing site and drug formulations. • Manufacturer can view their consolidated data about permissions issued to them from State FDA.
  • 9. INDIAN PHARMACEUTICAL ASSOCIATION 9 • Connecting The Pharmacistsand Pharmaceutical Scientists of India — The Indian PharmaceuticalAssociation (IPA) is the National body representing over 1 million pharmacists and pharmaceuticalscientists from Industry, Academia, Regulatory, Hospital and Community Pharmacy and work to meet the India’s health care needs. • IPA is a non-governmentalorganization that has been in official relations with the FIP and WHO. • IPA is member of Drug Technical Advisory Board (DTAB), Ministry of Health and Family Welfare, Government of India. • IPA has been awarded “Best Professional Organisation Award -2015” by Indian Association Congress.
  • 11. Drugs Technical Advisory Board •Drugs Technical Advisory Board is a statutory body constituted under the Drugs and Cosmetics Act, 1940. •The function of DTAB is to advise the Central government and State government on technical matters related to drugs and cosmetics. Section 3 of the Drugs and Cosmetics Act, 1940 •The Central Government, after consultation with the Drugs Technical Advisory Board (DTAB), specifies the devices intended for use in human beings or animals as drugs. 11
  • 12. 1.Central Drugs Testing Laboratory, Mumbai, Maharashtra 2.Central Drugs Laboratory, Kolkata, West Bengal 3.Central Drugs Testing Laboratory, Chennai, Tamil Nadu 4.Central Drugs Testing Laboratory, Hyderabad, Andhra Pradesh 5.Central Drugs Laboratory, Central Research Institute, Kasauli, Himachal Pradesh 6.Regional Drugs Testing Laboratory, Guwahati, Assam 7.Regional Drugs Testing Laboratory, Chandigarh A. Central Drugs Testing Laboratories 12
  • 13. 13
  • 14. 14
  • 15. The National Pharmaceutical Pricing Authority (NPPA) is a government regulatory agency that controls the prices of pharmaceutical drugs in India.[1].National Pharmaceutical Pricing Authority (NPPA) was constituted vide Government of India Resolution dated 29th August, 1997 as an attached office of the Department of Pharmaceuticals (DoP), Ministry of Chemicals and Fertilizers as an independent Regulator for pricing of drugs and to ensure availability and accessibility of medicines at affordable prices. 15
  • 16. The World Health Organization is a specialized agency of the United Nations responsible for international public health. The WHO Constitution, which establishes the agency's governing structure and principles, states its main objective as "the attainment by all peoples of the highest possible level of health". What is the WHO definition of health? Health is a state of complete physical, mental and social well-being and not merely the absence of disease or infirmity. 16
  • 17. 17
  • 18. The Indian Council of Medical Research (ICMR), New Delhi, the apex body in India for the formulation, coordination and promotion of biomedical research, is one of the oldest medical research bodies in the world. The Council's research priorities coincide with the National health priorities, such as: control and management of communicable diseases, fertility control, maternal and child health, control of nutritional disorders, developing alternative strategies for health care delivery, containment within safety limits of environmental and occupational health problems; research on major non- communicable diseases like cancer, cardiovascular diseases, blindness, diabetes and other metabolic and haematological disorders; and mental health research and drug research (including traditional remedies). 18
  • 19. 19
  • 20. 20
  • 21. 21
  • 22. 22
  • 23. 23